Back to Search
MEGAN DUPUIS, MD,PHD
MD,PHD
Medical Oncology Physician
NPI: 1952796385IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
63296(TN)R9943(TX)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
63296(TN)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
63296(TN)
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Sub-clinical diseases affecting performance in Standardbred trotters: diagnostic methods and predictive parameters.
PMID 19477143·Vet J·2010
7-preclinical
lmo1273, a novel gene involved in Listeria monocytogenes virulence.
PMID 19246760·Microbiology (Reading)·2009
7-preclinical
Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
PMID 19539558·Int Immunopharmacol·2009
7-preclinical
Hfq, a novel pleiotropic regulator of virulence-associated genes in Francisella tularensis.
PMID 19223477·Infect Immun·2009
7-preclinical
Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection.
PMID 19586617·Vascul Pharmacol·2009
4-observational
The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
PMID 19288261·Cancer Chemother Pharmacol·2009
8-other
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies.
PMID 19196867·Blood·2009
7-preclinical
Glutathione provides a source of cysteine essential for intracellular multiplication of Francisella tularensis.
PMID 19158962·PLoS Pathog·2009
7-preclinical
Combining radiotherapy with APO010 in cancer treatment.
PMID 19276268·Clin Cancer Res·2009
7-preclinical
Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge.
PMID 19028865·J Anim Sci·2009
7-preclinical
Two pathways for water interaction with oxygen adatoms on TiO2(110).
PMID 19392536·Phys Rev Lett·2009
8-other
Male partners of women with provoked vestibulodynia: attributions for pain and their implications for dyadic adjustment, sexual satisfaction, and psychological distress.
PMID 18637992·J Sex Med·2008
8-other
Development of human patient simulation programs: achieving big results with a small budget.
PMID 19010052·J Nurs Educ·2008
8-other
The H2O2+OH-->HO2+H2O reaction in aqueous solution from a charge-dependent continuum model of solvation.
PMID 18624482·J Chem Phys·2008
8-other
Kinetics of reduction of Fe(III) complexes by outer membrane cytochromes MtrC and OmcA of Shewanella oneidensis MR-1.
PMID 18791025·Appl Environ Microbiol·2008
8-other
A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
PMID 18789156·BMC Microbiol·2008
7-preclinical
Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis.
PMID 18692435·J Clin Virol·2008
8-other
Application of a kinetic energy partitioning scheme for ab initio molecular dynamics to reactions associated with ionization in water tetramers.
PMID 18688356·Phys Chem Chem Phys·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2301 ERWIN RD
DURHAM, NC 27705 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1952796385
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile